Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

Why Merit Medical Systems Stock Soared Today

By Keith Speights - Nov 1, 2019 at 5:01PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Some investors appeared to think that yesterday's sell-off was way overdone.

What happened

Shares of Merit Medical Systems ( MMSI 1.56% ) soared 16.9% higher on Friday. The medical device maker didn't announce any news, but some investors appeared to view the stock's big sell-off on Thursday as an opportunity to buy on the cheap. Merit Medical announced disappointing third-quarter results and lowered its full-year guidance after the market closed on Wednesday.

So what

It wasn't surprising that Merit Medical's shares sank after its dismal Q3 update. The company missed consensus Wall Street adjusted earnings estimates by a wide margin. But quite a few investors apparently felt that the sell-off was overdone. There's some merit (no pun intended) to that argument.

Businessman holding up a red arrow that's pointing upwards.

Image source: Getty Images.

Quite a few healthcare stocks experience seasonal sales volatility. Merit is no exception. CEO Fred P. Lampropoulos pointed out that the third quarter, which falls in the summer months, has historically "been the slowest quarter of the year" for the company.

The year-over-year comparisons looked even worse this year because a rival's inventory shortage in Q3 of 2018 artificially boosted Merit's sales. That being said, Merit does face some problems now that are more severe than in the past -- notably, higher tariffs and the potential negative impact of the U.K.'s exit from the European Union.

But yesterday's decline for Merit stock made the share price inexpensive enough that forward-looking investors stepped in to scoop up shares. These buyers are probably encouraged by Lampropoulos' statements that Merit believes that it has "been through the trough and [is] now emerging as a leaner, more efficient growth company."

Now what

Merit Medical has several things that could improve its fortunes going into 2020. The company recently executed a contract with group purchasing organization (GPO) Premier that allows the GPO's members to purchase Merit's interventional fluid-management products.

It recently secured preferred provider status with a major medical device distributor. Merit also continues to move forward with cost-cutting initiatives.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Merit Medical Systems, Inc. Stock Quote
Merit Medical Systems, Inc.
MMSI
$66.57 (1.56%) $1.02

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
652%
 
S&P 500 Returns
142%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/08/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.